- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07947784
Enhancing Cognitive and Postoperative Recovery After Cardiac Surgery in Older Adults (ECPON II) (ECPON II)
Enhancing Cognitive Function and POstoperative Neurocognitive Recovery After Cardiac Surgery in Older Adults
Postoperative cognitive complaints are common among older adults undergoing cardiac surgery and may negatively affect recovery, daily functioning, independence, and quality of life. The ECPON II study evaluates the effectiveness of a co-designed, nurse navigator-led intervention designed to support cognitive and postoperative recovery in older adults undergoing cardiac surgery.
Fifty patients aged 65 years or older undergoing cardiac surgery will receive the intervention. Outcomes will be compared with data from 150 matched historical controls from the previous ECPON observational study (ECPON I; NCT06469515). The historical controls are not enrolled in ECPON II.
The intervention consists of four coordinated components: information and education, postoperative consultations, cognitive assessments, and peer support, coordinated and delivered by a nurse navigator. The primary outcome is patient-reported cognitive complaints. Secondary outcomes include postoperative recovery, cognitive function, delirium, frailty, depression, health-related quality of life, functional capacity, self-efficacy, caregiver burden, and cost-utility. Participants will be followed for six months after surgery.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Postoperative neurocognitive impairment and cognitive complaints are important complications following cardiac surgery in older adults. Cognitive complaints may include difficulties with memory and concentration, fatigue, sleep disturbances, and reduced ability to manage everyday activities. These problems may influence postoperative recovery, independence, rehabilitation, and quality of life and may also affect close relatives.
ECPON II is a quasi-experimental superiority study evaluating a co-designed intervention coordinated and delivered by a nurse navigator. The intervention was developed through an experience-based co-design process involving older adults who had undergone surgery, close relatives, healthcare professionals, and scientific experts.
The intervention comprises four core components: (1) information and education regarding postoperative cognitive difficulties and strategies for managing them; (2) individualized postoperative consultations with a nurse navigator; (3) cognitive assessments before and after surgery to identify and follow cognitive difficulties and support individualized postoperative care; and (4) peer-support sessions for patients and close relatives.
Fifty patients aged 65 years or older undergoing open cardiac surgery will be prospectively enrolled and receive the intervention. Each patient will be asked to nominate a close relative who will be invited to participate in selected study activities. Close relatives will provide assessments of the patient's cognitive functioning and caregiver burden and may participate in peer-support sessions and qualitative interviews. If the patient has no close relative or the nominated person declines participation, the patient remains eligible for the study.
Outcomes in the intervention group will be compared with data from 150 matched historical controls from ECPON I (NCT06469515), an observational study conducted in the same patient population. The historical controls are used as comparator data and are not included in the ECPON II enrollment.
The primary objective is to determine whether the intervention reduces patient-reported cognitive complaints following cardiac surgery. Secondary objectives include evaluating postoperative recovery, cognitive function, self-efficacy, functional status, fatigue, depression, frailty, health-related quality of life, caregiver burden, and cost-utility.
A purposive sample of approximately 20-40 patients and their close relatives will participate in semi-structured individual interviews six months after surgery to explore experiences of the intervention, mechanisms of impact, feasibility, postoperative cognition, and recovery. In addition, all patients will be asked about any experience with postoperative delirium and, if so, to describe any long-term experiences as well as overall experience of postoperative cognition and its impact on recovery.
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Ulrica Nilsson, Professor
- E-mail: ulica.nilsson@ki.se
Estude backup de contato
- Nome: Lina Bergman, PhD
- Número de telefone: 0046 33 435 44 11
- E-mail: lina.bergman@hb.se
Locais de estudo
-
-
-
Gothenburg, Suécia
- Sahlgrenska University Hospital, Gothenburg
-
Contato:
- Tor Damén, MD, PhD
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Scheduled for elective or urgent open-heart surgery or minimally invasive cardiac surgery
- Resident in the area/region for the current thoracic clinic
- Able to read and understand Swedish
Exclusion Criteria:
- Physical, mental, and cognitive difficulties that prevent the individual from completing the cognitive tests
- Undergone surgery within the last 6 months
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: ECPON II Nurse Navigator-led Intervention
|
The intervention comprises four coordinated components:
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Patient-reported cognitive complaints
Prazo: Preoperatively and weekly from 3-5 days after discharge through 6 months after surgery.
|
Patient-reported cognitive complaints will be assessed using the Cognitive Recovery dimension of the Swedish Quality of Recovery-Cognitive (SwQoR-Cog). The dimension comprises 10 items assessing symptoms related to cognitive complaints, including fatigue, sleep difficulties, concentration difficulties, frustration, forgetfulness, difficulties reading or calculating, and reduced ability to function independently. Each symptom is rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time"), with higher scores indicating a greater symptom burden. |
Preoperatively and weekly from 3-5 days after discharge through 6 months after surgery.
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Postoperative recovery
Prazo: Preoperatively and weekly through 6 months
|
Evaluated with the General recovery dimension of the SwQoR-Cog, consisting of 4 items measuring symptoms related to pain, nausea, the wound, and difficulties with personal hygiene. Each item is rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time"), with higher scores indicating a greater symptom burden. |
Preoperatively and weekly through 6 months
|
|
Nightmares
Prazo: Weekly through 6 months
|
Patient-reported frequency/severity of nightmares rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time"). |
Weekly through 6 months
|
|
Cognitive function
Prazo: Preoperatively, 1 month, 3 months and 6 months
|
Consortium to Establish a Registry for Alzheimer's Disease (CERAD). The CERAD measures verbal learning and memory performance. Participants are presented with a list of 10 words across three learning trials and asked to recall as many words as possible after each trail. |
Preoperatively, 1 month, 3 months and 6 months
|
|
Executive functioning
Prazo: Preoperatively, 1 month, 3 months and 6 months
|
Stroop Colour-Word Interference Test (SCWT) is used to assess executive functioning, selective attention, and inhibitory control. In this timed test, participants are required to identify the colour of words printed in incongruent colours as quickly and accurately as possible |
Preoperatively, 1 month, 3 months and 6 months
|
|
Postoperative delirium
Prazo: Three times daily during hospitalization
|
Nursing Delirium Screening Scale (Nu-DESC). The scale assesses five symptom domains associated with delirium, with higher scores reflecting greater symptom severity. A total score of 2 or above is considered indicative of delirium. |
Three times daily during hospitalization
|
|
Frailty
Prazo: Preoperatively and 6 months
|
Clinical Frailty Scale (CFS), a nine-point instrument that classifies individuals from very fit to terminally ill. Assessments are conducted by trained clinicians based on the individual's pre-illness functional status. |
Preoperatively and 6 months
|
|
Depressive symptoms
Prazo: Preoperatively, 1 month, 3 months and 6 months
|
Patient Health Questionnaire-9 (PHQ-9), nine items assessing depressive symptoms experienced during the preceding two weeks, with response options ranging from 0 ("not at all") to 3 ("nearly every day"). |
Preoperatively, 1 month, 3 months and 6 months
|
|
Health-related quality of life
Prazo: Preoperatively and 6 months
|
RAND-36 questionnaire encompassing eight dimensions of health: physical functioning, physical role limitations, emotional role limitations, vitality, mental health, social functioning, pain, and general health. Domain scores as well as physical and mental summary scores will be calculated to provide an overall assessment of health status. |
Preoperatively and 6 months
|
|
Functional capacity
Prazo: Preoperatively, 1 month, 3 months and 6 months
|
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0), 12-item version. This instrument evaluates difficulties in performing everyday activities and participating in daily life in relation to an individual's current health status. Each item is rated on a five-point scale reflecting the degree of difficulty experienced, generating a total score ranging from 0 to 48. Higher scores indicate greater disability and functional limitations |
Preoperatively, 1 month, 3 months and 6 months
|
|
Self-efficacy
Prazo: Preoperatively, 1 month, 3 months and 6 months
|
General Self-Efficacy Scale (GSE), 10 items assessing an individual's perceived ability to handle demanding situations and solve problems effectively. Items are rated on a four-point scale, and higher scores reflect greater self-efficacy. |
Preoperatively, 1 month, 3 months and 6 months
|
|
Cognitive functioning assessed by close relatives
Prazo: Preoperatively, 1 month, 3 months and 6 months
|
Cognitive Failures Questionnaire for Others (CFQ-f). The questionnaire contains eight items measuring observed cognitive difficulties in daily life, with responses provided on a five-point scale from never to always. The instrument has been translated and culturally adapted for Swedish use by our research group following back-translation procedures. The recall period was shortened from six months in the original version to one month to better reflect the postoperative recovery trajectory. |
Preoperatively, 1 month, 3 months and 6 months
|
|
Caregiver burden
Prazo: Preoperatively, 1 month, 3 months and 6 months
|
Zarit Burden Interview, 12-item version (ZBI-12). The instrument contains 12 items, each rated on a five-point Likert scale ranging from never to nearly always. |
Preoperatively, 1 month, 3 months and 6 months
|
|
Plasma osmolality
Prazo: Preoperatively and postoperative day 1
|
Osmolality will be estimated using the blood-based biomarkers sodium, glucose, and urea and calculated according to the following formula: Osmolarity (mOsm/L) = 2 × Sodium (mmol/L) + Glucose (mg/dL) / 18 + Urea (mg/dL) / 2.8. |
Preoperatively and postoperative day 1
|
|
Cost-utility
Prazo: Through 6 months
|
Will be assessed by calculating quality-adjusted life years (QALYs) gained using data obtained from the RAND-36. |
Through 6 months
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Demographic and perioperative data
Prazo: At baseline and perioperatively
|
Will be collected from the medical record. |
At baseline and perioperatively
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Estimado)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2026-06328-01
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .